Navigation Links
Dyadic International Reports 2010 Third Quarter Financial Results
Date:11/15/2010

OFT BioACE 5X, a new acid cellulase product for the Asian textile market

Biofuels

  • Developed an improved seventh generation of a C1 biofuels strain which produces a mix of enzymes that is more efficient in releasing sugars from waste streams containing ligno-cellulosic materials than previous C1 biofuels strains
  • Initiated discussions with new potential partners and continued ongoing dialogue with companies for the potential license of Dyadic's C1 technology for the development and commercialization of biofuels and biochemicals

    • Biopharmaceuticals

  • Continued discussions with several companies and investors regarding the potential funding of EnGen Bio, Inc., Dyadic's prospective exclusive licensee of its C1 platform technology for biopharmaceutical applications, which was recently awarded a cash grant of approximately $250,000 under the U.S. Government's Qualifying Therapeutic Discovery Project program

    • Research & Development

  • Demonstrated the capability of Dyadic's C1 platform technology in third party-funded research and development projects to over-express heterologous genes for the production of certain proteins and enzymes at substantially higher levels than the original producing organism and are leveraging these results through further collaborations to improve the cost structure of new and existing products in a variety of industries
  • Continued to improve the efficiency and performance of Dyadic's enzymes for use in creating new industrial enzyme products and enhancing Dyadic's current product offerings in the areas of animal feed, pulp and paper, starch and alcohol, food and brewing, textiles and alternative fuels
  • Continued to enhance our C1 technology and mine for novel genes through the annotation project that was conducted in collaboration with Scripps Florida, a division of the Scripps Research Institute, and Dyadic Netherlands, for greater applicability in producing higher
    '/>"/>

    • SOURCE Dyadic International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
    2. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
    3. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
    4. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
    5. Dyadic International Engages The Abraham Group as Strategic Advisor
    6. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
    7. Dyadic International Strengthens Management Team
    8. Dyadic International Extends Collaboration With The Scripps Research Institute
    9. International Technidyne Corporation Acquired by Warburg Pincus
    10. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
    11. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/16/2013)... (PRWEB) May 16, 2013 ... Barbara A. Myers, CAE, to the newly created ... her new role, Myers will be responsible for ... and production strategies, advancing the Society’s Member-led and ... and continuing to refine organizational, membership and product ...
    (Date:5/16/2013)... 16, 2013 Cambridge Healthtech Institute will ... 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, ... a close-up look at the current strategies and innovations ... quality. Leaders in the field will reveal how ... biopharmaceuticals with greater specificity and efficiency. , “In this ...
    (Date:5/16/2013)... -- Scientists at the Center for Learning and Memory, ... California -based biopharmaceutical company Magceutics, Inc. ... reversing memory decline in mice with Alzheimer,s Disease. By ... in advanced stage AD mice. The study is the ... for advanced stage AD mice, and is also the ...
    (Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ... MediPoint: Diagnostic Cardiac Biomarkers for ... and Market Forecasts ... Cardiac Biomarkers for Acute Coronary Syndromes ...
    Breaking Biology Technology:ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8
    ... - The Wisconsin Health Information Exchange has ... the State of Wisconsin for calendar year 2006. ... as a not-for-profit 501c3 entity, to develop its governance ... potentially significant community health events through sharp increases in ...
    ... - Brady Corp. has raised approximately ... common stock. , ,Brady, a global manufacturer of identification solutions, ... A common stock at $36 per share. The company intends ... amounts under its revolving credit facility and for general corporate ...
    ... merging of complementary companies, Cytochroma, Inc ., a Canadian ... Proventiv Therapeutics, LLC, of Madison, and the combined company is ... Canadian and American investors. , ,Proventiv was founded in Sept. ... which was acquired last year by Genzyme Corp ., ...
    Cached Biology Technology:WHIE receives state eHealth Initiative contract 2Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO 2Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO 3
    (Date:5/16/2013)... choose to wear the color red when they compete? ... Science , a journal of the Association for Psychological ... their testosterone levels. , The new study, conducted by ... and colleagues, demonstrated that males who chose red as ... levels than other males who chose blue. , "The ...
    (Date:5/16/2013)... discovered an ancient extinct creature with ,scissor hand-like, claws ... of his favourite movie star. , The 505 ... (pronounced Koo-ten-ee-che-la depp-eye), which is a distant ancestor of ... Depp for his starring role as Edward Scissorhands - ... unfinished creation, who has scissors for hands. , ...
    (Date:5/16/2013)... outside the bone marrow in the liver, the ... now show that a specific type of immune cell ... Balanced hematopoiesis is essential for the function of the ... in the liver and the spleen. Later the process ... normally serves as the sole source of blood cells ...
    Breaking Biology News(10 mins):High-testosterone competitors more likely to choose red 2Actor Johnny Depp immortalized in ancient fossil find 2Herpes infections: Natural killer cells activate hematopoiesis 2
    ... PHILADELPHIA A recent report in Cancer Epidemiology, ... for Cancer Research, adds to the growing evidence that fish ... Researchers at the Fred Hutchinson Cancer Research Center ... of the public health sciences division, asked 35,016 postmenopausal women ...
    ... which maize (corn) evolved, might be forgiven for assuming many ... other. However, a method for exploring the genetics of ... only modest modifications are needed to convert a wild plant ... even be achieved by a single genetic change. The ...
    ... double by 2050 to address rising population and demand, ... yields will suffer unless new approaches to adapt crop ... responsible for the remarkable increases in yield accomplished during ... some of the world,s most important crops. ...
    Cached Biology News:Fish oil may reduce risk of breast cancer 2What plant genes tell us about crop domestication 2What plant genes tell us about crop domestication 3What plant genes tell us about crop domestication 4What plant genes tell us about crop domestication 5'Business as usual' crop development won't satisfy future demand 2'Business as usual' crop development won't satisfy future demand 3
    Mouse monoclonal antibody raised against a partial recombinant ALAS2. NCBI Entrez Gene ID = ALAS2...
    96-well format (For processing samples on microplate-size MALDI target plates such as those from Bruker, Shimadzu, Thermo, and PerkinElmer) Packaging: 2 / pack...
    Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
    ...
    Biology Products: